BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10365723)

  • 1. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
    Wolfe JL; Thoma LA; Du C; Goldspiel BR; Gallelli JF; Grimes GJ; Potti GK
    Am J Health Syst Pharm; 1999 May; 56(10):985-9. PubMed ID: 10365723
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
    Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
    Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
    Svirskis D; Behera S; Naidoo N; Beachman J; Raina T; Zhou Y; Berkahn L; Costello I; Gu Y
    J Oncol Pharm Pract; 2019 Jun; 25(4):831-840. PubMed ID: 29540104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of intravenous admixtures of doxorubicin and vincristine.
    Beijnen JH; Neef C; Meuwissen OJ; Rutten JJ; Rosing H; Underberg WJ
    Am J Hosp Pharm; 1986 Dec; 43(12):3022-7. PubMed ID: 3812509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
    Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
    Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
    Barthes DM; Rochard EB; Pouliquen IJ; Rabouan SM; Courtois PY
    Am J Hosp Pharm; 1994 Nov; 51(21):2706-9. PubMed ID: 7856587
    [No Abstract]   [Full Text] [Related]  

  • 8. Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
    Ku YM; Min DI; Kumar V; Noormohamed SE
    Am J Health Syst Pharm; 1995 Sep; 52(18):2024-5. PubMed ID: 8528874
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability of doxorubicin hydrochloride and vincristine sulfate in two portable infusion-pump reservoirs.
    Nyhammar EK; Johansson SG; Seiving BE
    Am J Health Syst Pharm; 1996 May; 53(10):1171-3. PubMed ID: 8734681
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability and compatibility of antitumor agents in glass and plastic containers.
    Benvenuto JA; Anderson RW; Kerkof K; Smith RG; Loo TL
    Am J Hosp Pharm; 1981 Dec; 38(12):1914-8. PubMed ID: 7325172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
    Stewart JT; Warren FW; King DT; Venkateshwaran TG; Ponder GW; Fox JL
    Am J Health Syst Pharm; 1997 Apr; 54(8):915-20. PubMed ID: 9114924
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of cisplatin and etoposide in intravenous admixtures.
    Stewart CF; Hampton EM
    Am J Hosp Pharm; 1989 Jul; 46(7):1400-4. PubMed ID: 2757048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Dec; 54(23):2708-13. PubMed ID: 9408515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of bupivacaine hydrochloride and morphine sulfate.
    Johnson CE; Christen C; Perez MM; Ma M
    Am J Health Syst Pharm; 1997 Jan; 54(1):61-4. PubMed ID: 9117792
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection.
    Nolan PE; Hoyer GL; LeDoux JH; Fox JL
    Am J Health Syst Pharm; 1997 Jun; 54(11):1304-6. PubMed ID: 9179353
    [No Abstract]   [Full Text] [Related]  

  • 16. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C.
    Xu Q; Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Dec; 51(24):3058-60. PubMed ID: 7856626
    [No Abstract]   [Full Text] [Related]  

  • 18. Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
    Trissel LA; Xu QA; Gilbert DL
    Ann Pharmacother; 1998 Oct; 32(10):1013-6. PubMed ID: 9793591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
    Lee DK; Wang DP; Harsono R; Wong CY
    Am J Health Syst Pharm; 2005 Jun; 62(11):1190-2. PubMed ID: 15914879
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection.
    Kintzel PE; Zhao T; Wen B; Sun D
    Am J Health Syst Pharm; 2014 Dec; 71(23):2061-5. PubMed ID: 25404598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.